Lipocalin 2(LCN2)plays a pivotal role in iron metabolism,particularly in the context of microbial infection resistance(e.g.,viruses,bacteria,parasites,etc.).LCN2 combats microbial infection by directly assisting the b...Lipocalin 2(LCN2)plays a pivotal role in iron metabolism,particularly in the context of microbial infection resistance(e.g.,viruses,bacteria,parasites,etc.).LCN2 combats microbial infection by directly assisting the body in competing with microorganisms for iron,inducing immune cells to secrete various cytokines to enhance systemic immune responses,or recruiting neutrophils to infectious sites.The liver serves as the primary organ for LCN2 secretion during microbial infections.This review encapsulates recent advances in dynamic changes,clinical values,and the effects of LCN2 in infectious liver diseases caused by various microbial microorganisms.展开更多
Objective To identify serum diagnosis or progression biomarkers in patients with lung cancer using protein chip profiling analysis. Method Profiling analysis was performed on 450 sera collected from 213 patients with ...Objective To identify serum diagnosis or progression biomarkers in patients with lung cancer using protein chip profiling analysis. Method Profiling analysis was performed on 450 sera collected from 213 patients with lung cancer, 19 with pneumonia, 16 with pulmonary tuberculosis, 65 with laryngeal carcinoma, 55 with laryngopharyngeal carcinoma patients, and 82 normal individuals. A new strategy was developed to identify the biomarkers on chip by trypsin pre-digestion. Results Profiling analysis demonstrated that an 11.6kDa protein was significandy elevated in lung cancer patients, compared with the control groups （P〈0.001）. The level and percentage of 11.6kDa protein progressively increased with the clinical stages Ⅰ-Ⅳ and were also higher in patients with squamous cell carcinoma than in other subtypes. This biomarker could be decreased after operation or chemotherapy. On the other hand, 11.6kDa protein was also increased in 50% benign diseases of lung and 13% of other cancer controls. After trypsin pre-digestion, a set of new peptide biomarkers was noticed to appear only in the samples containing a 11.6kDa peak. Further identification showed that 2177Da was a fragment of serum amyloid A （SAA, MW 11.6kDa）. Two of the new peaks, 1550Da and 1611Da, were defined from the same protein by database searching. This result was further confirmed by partial purification of 11.6kDa protein and MS analysis. Conclusion SAA is a useful biomarker to monitor the progression of lung cancer and can directly identify some biomarkers on chip.展开更多
In this paper,the metastableβTB8 titanium alloy with nanocrystallineαphase is achieved by electric pulse treatment.The morphology evolution and variant selection of nanocrystallineαphase in metastableβTB8titanium ...In this paper,the metastableβTB8 titanium alloy with nanocrystallineαphase is achieved by electric pulse treatment.The morphology evolution and variant selection of nanocrystallineαphase in metastableβTB8titanium alloy were investigated by using scanning electron microscope(SEM),electron backscattered diffraction(EBSD)and transmission electron microscope(TEM)analysis.The results indicated that the morphologies of the nanocrystallineαphase were mainly triangular clusters and needle-like at the pressure of 0 MPa.With increasing pressure from 20 to 50 MPa,the volume fraction of needlelikeαphase decreased,and a large amount of V-shapedαphase formed in the interior ofβgrains.Based on the EBSD data,the parentβphase was reconstructed by MTEX software.In the interior of theβgrains,12 variants can form for the samples electric pulse treated at 0 and20 MPa,while only 3 and 6 variants can form for the samples electric pulse treated at 30 and 50 MPa.In the grain boundary of theβgrains,one or more grain boundaryαvariants can be generated for the samples electric pulse treated at different pressures as long as one of the neighborβgrains follows the Burgers orientation relationship.展开更多
Background:The global pandemic coronavirus disease 2019(COVID-19)has become a major public health problem and presents an unprecedented challenge.However,no specific drugs were currently proven.This study aimed to eva...Background:The global pandemic coronavirus disease 2019(COVID-19)has become a major public health problem and presents an unprecedented challenge.However,no specific drugs were currently proven.This study aimed to evaluate the comparative efficacy and safety of pharmacological interventions in patients with COVID-19.Methods:Medline,Embase,the Cochrane Library,and clinicaltrials.gov were searched for randomized controlled trials(RCTs)in patients infected with severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)/SARS-CoV.Random-effects network metaanalysis within the Bayesian framework was performed,followed by the Grading of Recommendations Assessment,Development,and Evaluation system assessing the quality of evidence.The primary outcome of interest includes mortality,cure,viral negative conversion,and overall adverse events(OAEs).Odds ratio(OR)with 95%confidence interval(CI)was calculated as the measure of effect size.Results:Sixty-six RCTs with 19,095 patients were included,involving standard of care(SOC),eight different antiviral agents,six different antibiotics,high and low dose chloroquine(CQ_HD,CQ_LD),traditional Chinese medicine(TCM),corticosteroids(COR),and other treatments.Compared with SOC,a significant reduction of mortality was observed for TCM(OR=0.34,95%CI:0.20–0.56,moderate quality)and COR(OR=0.84,95%CI:0.75–0.96,low quality)with improved cure rate(OR=2.16,95%CI:1.60–2.91,low quality for TCM;OR=1.17,95%CI:1.05–1.30,low quality for COR).However,an increased risk of mortality was found for CQ_HD vs.SOC(OR=3.20,95%CI:1.18–8.73,low quality).TCM was associated with decreased risk of OAE(OR=0.52,95%CI:0.38–0.70,very low quality)but CQ_HD(OR=2.51,95%CI:1.20–5.24)and interferons(IFN)(OR=2.69,95%CI:1.02–7.08)vs.SOC with very low quality were associated with an increased risk.Conclusions:COR and TCM may reduce mortality and increase cure rate with no increased risk of OAEs compared with standard care.CQ_HD might increase the risk of mortality.CQ,IFN,and other antiviral agents could increase the risk of OAEs.The current evidence is generally uncertain with low-quality and further high-quality trials are needed.展开更多
To the Editor:Hepatitis B virus(HBV)infection is a major global health problem associated with liver-related morbidity and mortality.Chronic HBV infection,defined as hepatitis B surface antigen(HBsAg)positivity,affect...To the Editor:Hepatitis B virus(HBV)infection is a major global health problem associated with liver-related morbidity and mortality.Chronic HBV infection,defined as hepatitis B surface antigen(HBsAg)positivity,affecting approximately 257 million people worldwide.Chronic infection with HBV may result in the development of cirrhosis,liver failure,and hepatocellular carcinoma(HCC).Liver transplantation(LT)remains the only curative treatment for HBV-related end-stage liver diseases.展开更多
文摘Lipocalin 2(LCN2)plays a pivotal role in iron metabolism,particularly in the context of microbial infection resistance(e.g.,viruses,bacteria,parasites,etc.).LCN2 combats microbial infection by directly assisting the body in competing with microorganisms for iron,inducing immune cells to secrete various cytokines to enhance systemic immune responses,or recruiting neutrophils to infectious sites.The liver serves as the primary organ for LCN2 secretion during microbial infections.This review encapsulates recent advances in dynamic changes,clinical values,and the effects of LCN2 in infectious liver diseases caused by various microbial microorganisms.
基金Project(2016YFE0205700)supported by the National Key Research and Development Program of ChinaProject(18JCYBJC18000)supported by the Natural Science Foundation of Tianjin City,China。
基金This work was supported by the National Natural Science Foundation of China (Grant No.30370712)Beijing Key Project (Grant No. 7051002)+1 种基金 Beijing Science Technology Committee Project (No.Y0204002040111)a grant of Majon State Basic Research Program of China (No. 2006CB 910100).
文摘Objective To identify serum diagnosis or progression biomarkers in patients with lung cancer using protein chip profiling analysis. Method Profiling analysis was performed on 450 sera collected from 213 patients with lung cancer, 19 with pneumonia, 16 with pulmonary tuberculosis, 65 with laryngeal carcinoma, 55 with laryngopharyngeal carcinoma patients, and 82 normal individuals. A new strategy was developed to identify the biomarkers on chip by trypsin pre-digestion. Results Profiling analysis demonstrated that an 11.6kDa protein was significandy elevated in lung cancer patients, compared with the control groups （P〈0.001）. The level and percentage of 11.6kDa protein progressively increased with the clinical stages Ⅰ-Ⅳ and were also higher in patients with squamous cell carcinoma than in other subtypes. This biomarker could be decreased after operation or chemotherapy. On the other hand, 11.6kDa protein was also increased in 50% benign diseases of lung and 13% of other cancer controls. After trypsin pre-digestion, a set of new peptide biomarkers was noticed to appear only in the samples containing a 11.6kDa peak. Further identification showed that 2177Da was a fragment of serum amyloid A （SAA, MW 11.6kDa）. Two of the new peaks, 1550Da and 1611Da, were defined from the same protein by database searching. This result was further confirmed by partial purification of 11.6kDa protein and MS analysis. Conclusion SAA is a useful biomarker to monitor the progression of lung cancer and can directly identify some biomarkers on chip.
基金financially supported by the National Natural Science Foundation of China(Nos.51804087 and 52161010)the Science and Technology Programs of Guiyang(No.[2021]1-7)the Breeding Programs of Guizhou University(Nos.[2019]16 and[2020]21)。
文摘In this paper,the metastableβTB8 titanium alloy with nanocrystallineαphase is achieved by electric pulse treatment.The morphology evolution and variant selection of nanocrystallineαphase in metastableβTB8titanium alloy were investigated by using scanning electron microscope(SEM),electron backscattered diffraction(EBSD)and transmission electron microscope(TEM)analysis.The results indicated that the morphologies of the nanocrystallineαphase were mainly triangular clusters and needle-like at the pressure of 0 MPa.With increasing pressure from 20 to 50 MPa,the volume fraction of needlelikeαphase decreased,and a large amount of V-shapedαphase formed in the interior ofβgrains.Based on the EBSD data,the parentβphase was reconstructed by MTEX software.In the interior of theβgrains,12 variants can form for the samples electric pulse treated at 0 and20 MPa,while only 3 and 6 variants can form for the samples electric pulse treated at 30 and 50 MPa.In the grain boundary of theβgrains,one or more grain boundaryαvariants can be generated for the samples electric pulse treated at different pressures as long as one of the neighborβgrains follows the Burgers orientation relationship.
基金the National Natural Science Foundation of China(No.72074011)the Special Project for Major Infectious Disease of Peking University Health Program of China(No.BMU2020HKYZX010)the National Key Technology R&D Program of China(No.2020YFC0840800).
文摘Background:The global pandemic coronavirus disease 2019(COVID-19)has become a major public health problem and presents an unprecedented challenge.However,no specific drugs were currently proven.This study aimed to evaluate the comparative efficacy and safety of pharmacological interventions in patients with COVID-19.Methods:Medline,Embase,the Cochrane Library,and clinicaltrials.gov were searched for randomized controlled trials(RCTs)in patients infected with severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)/SARS-CoV.Random-effects network metaanalysis within the Bayesian framework was performed,followed by the Grading of Recommendations Assessment,Development,and Evaluation system assessing the quality of evidence.The primary outcome of interest includes mortality,cure,viral negative conversion,and overall adverse events(OAEs).Odds ratio(OR)with 95%confidence interval(CI)was calculated as the measure of effect size.Results:Sixty-six RCTs with 19,095 patients were included,involving standard of care(SOC),eight different antiviral agents,six different antibiotics,high and low dose chloroquine(CQ_HD,CQ_LD),traditional Chinese medicine(TCM),corticosteroids(COR),and other treatments.Compared with SOC,a significant reduction of mortality was observed for TCM(OR=0.34,95%CI:0.20–0.56,moderate quality)and COR(OR=0.84,95%CI:0.75–0.96,low quality)with improved cure rate(OR=2.16,95%CI:1.60–2.91,low quality for TCM;OR=1.17,95%CI:1.05–1.30,low quality for COR).However,an increased risk of mortality was found for CQ_HD vs.SOC(OR=3.20,95%CI:1.18–8.73,low quality).TCM was associated with decreased risk of OAE(OR=0.52,95%CI:0.38–0.70,very low quality)but CQ_HD(OR=2.51,95%CI:1.20–5.24)and interferons(IFN)(OR=2.69,95%CI:1.02–7.08)vs.SOC with very low quality were associated with an increased risk.Conclusions:COR and TCM may reduce mortality and increase cure rate with no increased risk of OAEs compared with standard care.CQ_HD might increase the risk of mortality.CQ,IFN,and other antiviral agents could increase the risk of OAEs.The current evidence is generally uncertain with low-quality and further high-quality trials are needed.
文摘To the Editor:Hepatitis B virus(HBV)infection is a major global health problem associated with liver-related morbidity and mortality.Chronic HBV infection,defined as hepatitis B surface antigen(HBsAg)positivity,affecting approximately 257 million people worldwide.Chronic infection with HBV may result in the development of cirrhosis,liver failure,and hepatocellular carcinoma(HCC).Liver transplantation(LT)remains the only curative treatment for HBV-related end-stage liver diseases.
